American Shared Hospital Services AI Stock Analysis
Want to see AMS full AI Analyst Report?
American Shared Hospital Services (AMS) AI Stock Analysis
American Shared Hospital Services
(NYSE MKT:AMS)
The overall score of 48 reflects a company with a solid financial foundation but facing significant operational and market headwinds. The primary support comes from a strong, deleveraged balance sheet and robust cash flow generation, which provide a critical buffer. However, this is heavily offset by severe profitability issues, including margin compression and net losses, as highlighted in both financial statements and the earnings call. The stock's bearish technical trend and negative P/E ratio further weigh on the score, indicating a high-risk profile with limited near-term positive catalysts until profitability stabilizes.
American Shared Hospital Services (AMS) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $7.18M
- Dividend Yield
- ―
- Average Volume (3M)
- 10.54K
- Price to Earnings (P/E)
- -3.2
- Beta (1Y)
- 0.25
- Revenue Growth
- 4.90%
- EPS Growth
- -3.41%
- Country
- US
- Employees
- 83
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
American Shared Hospital Services Business Overview & Revenue Model
Company Description
American Shared Hospital Services specializes in leasing advanced radiosurgery and radiation therapy equipment to healthcare providers. The company offers Gamma Knife stereotactic radiosurgery systems, a non-invasive technology used to treat conditio...
How the Company Makes Money
AMS primarily makes money by enabling hospitals and treatment centers to provide advanced radiation therapy without those providers bearing the full upfront burden of owning and operating the technology. Its revenue model typically centers on long-te...
American Shared Hospital Services Earnings Call Summary
The call presented meaningful operational and revenue growth, particularly in Direct Patient Services, international Gamma Knife procedures, cash generation and development opportunities. However, profitability weakened, with lower gross margins and EBITDA, higher legal and consulting expenses, widening net losses, lower procedure volumes at certain facilities and continued reliance on resolving creditor and capital-structure matters. The overall tone was mixed, with management expressing confidence in the company’s growth prospects while acknowledging significant financial and operational challenges.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management said it remains focused on driving continued revenue growth, increasing utilization, improving operating efficiency, managing costs, improving operating cash flow and expanding its installed base of advanced radiation therapy technologies. The company currently expects the Hospital San Javier facility in Guadalajara, Mexico, to begin treating patients in mid-2027 and expects to be operational in mid-2027; the upgraded Gamma Knife would be 1 of only 3 Gamma Knives in the country of Mexico. The proton beam system project is pursuing an asset-light philosophy, while the Bristol, Rhode Island linear accelerator and Johnston, Rhode Island proton beam system projects are in the design phase with not much CapEx incurred quite yet. Management said it feels there's still opportunity to improve gross margins, and when banking, legal and consulting costs go away, it should improve operating margin levels. The company generated approximately $5.8 million of cash from operations in the first nine months, had $9.5 million of cash against roughly $15 million of indebtedness with Fifth Third, and has a forbearance agreement through June 30, 2027.
American Shared Hospital Services Financial Statement Overview
Summary
Financial performance is mixed. The balance sheet is strong with low debt (D/E 0.18) and the cash flow is robust ($6.9M TTM FCF), providing a safety net. However, the income statement is weak, with collapsing gross margins (16.7% TTM) and significant net losses (-$2.4M TTM) despite strong revenue growth. The cash flow strength offsets some income statement weakness.
Income Statement
35NegativeBalance Sheet
72PositiveCash Flow
78Positive| Breakdown | TTM | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.87M | 28.08M | 28.34M | 21.32M | 19.75M | 17.63M |
| Gross Profit | 5.15M | 5.04M | 9.19M | 9.34M | 8.38M | 6.73M |
| EBITDA | 2.61M | 4.07M | 8.91M | 6.97M | 8.11M | 6.97M |
| Net Income | -2.38M | -1.55M | 2.19M | 610.00K | 1.33M | 194.00K |
Balance Sheet | ||||||
| Total Assets | 52.87M | 55.48M | 60.20M | 48.16M | 43.96M | 45.43M |
| Cash, Cash Equivalents and Short-Term Investments | 9.48M | 3.46M | 11.03M | 13.69M | 12.34M | 8.14M |
| Total Debt | 4.10M | 22.61M | 23.23M | 17.64M | 14.31M | 17.47M |
| Total Liabilities | 27.84M | 27.79M | 30.17M | 21.88M | 18.33M | 21.19M |
| Stockholders Equity | 22.61M | 24.03M | 25.18M | 22.62M | 21.63M | 19.89M |
Cash Flow | ||||||
| Free Cash Flow | 6.91M | -4.54M | -7.77M | -555.00K | 6.85M | 4.59M |
| Operating Cash Flow | 5.10M | 3.10M | 167.00K | 5.72M | 7.24M | 6.27M |
| Investing Cash Flow | 1.81M | -7.63M | -7.11M | -6.27M | -388.00K | -1.67M |
| Financing Cash Flow | -2.77M | -3.03M | 4.41M | 1.91M | -2.66M | -655.00K |
American Shared Hospital Services Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AMS, the sentiment is Negative. The current price of 1.08 is below the 20-day moving average (MA) of 1.22, below the 50-day MA of 1.33, and below the 200-day MA of 1.57, indicating a bearish trend. The MACD of -0.06 indicates Positive momentum. The RSI at 27.88 is Positive, neither overbought nor oversold. The STOCH value of 28.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AMS.
American Shared Hospital Services Risk Analysis
American Shared Hospital Services disclosed 25 risk factors in its most recent earnings report. American Shared Hospital Services reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksAmerican Shared Hospital Services Peers Comparison
Overall Rating
PACS71Outperform
ARDT68Neutral
SGRY51Neutral
AMS48Neutral
CYH44Neutral
CCM40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 71Outperform | $7.67B | 27.61 | 25.77% | ― | 11.02% | 62.56% | |
| 68Neutral | $2.51B | 17.11 | 9.48% | ― | 2.03% | -28.50% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 51Neutral | $3.53B | -40.22 | -5.17% | ― | 2.19% | 50.06% | |
| 48Neutral | $7.18M | -3.18 | -10.19% | ― | 4.90% | -3.41% | |
| 44Neutral | $315.90M | 8.30 | -2.51% | ― | -7.84% | -88.93% | |
| 40Underperform | $15.72M | -0.03 | 5.16% | ― | 20.26% | 69.68% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| AMS | American Shared Hospital Services | 1.08 | -1.08 | -50.00% | |
| CYH | Community Health Systems | 2.24 | -0.77 | -25.58% | |
| CCM | Concord Medical Services | 3.62 | -0.68 | -15.81% | |
| SGRY | Surgery Partners Inc. | 26.95 | 11.89 | 78.95% | |
| PACS | PACS Group Inc | 48.32 | 32.62 | 207.77% | |
| ARDT | Ardent Health Partners, Inc. | 17.80 | 9.52 | 114.98% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 14, 2026
